# Complexity Ratios

In methodological complexity analysis, does the design sophistication of African trials match the complexity of the health problems they seek to address? This audit computed a composite complexity index from design features including adaptive elements (140 trials), Bayesian methods (20), platform designs (152), and biomarker stratification (1,149) for 23,873 African trials on ClinicalTrials.gov through March 2026. Africa's composite complexity index of 0.32 compared to 0.78 in the United States indicates that African trials employ simpler designs despite addressing complex multi-morbidity patterns unique to the continent. The low adoption of adaptive methods (140 versus 2,986 in the United States) is particularly significant given Africa's resource constraints where efficient designs could reduce sample sizes and costs. Cluster-randomised trials (452) showed relative strength, reflecting community-level intervention delivery. These findings reveal a complexity mismatch between Africa's trial designs and its epidemiological challenges. Interpretation is limited by keyword-based complexity assessment.

## References

1. Alemayehu C, et al. "Behind the mask of the African clinical trials landscape." Trials. 2018;19:519.
2. Drain PK, et al. "Global migration of clinical trials." Nat Rev Drug Discov. 2018;17:765-766.

## Note Block

- Type: research
- App: https://mahmood726-cyber.github.io/africa-e156-students/methods-systems/dashboards/angle-21_complexity-ratios.html
- Code: https://github.com/mahmood726-cyber/africa-e156-students/blob/master/methods-systems/code/angle-21-complexity-ratios.py
- Data: ClinicalTrials.gov API v2
- Date: 2026-04-05